This article was written by Follow Buyside analyst covering global stocks on Seeking Alpha since 2018. I’ve been investing personally and professionally across major...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
The Shopify Investment Thesis Appears Bright, Thanks To The Two Pronged Approach We previously covered Shopify (NYSE:SHOP) in May 2023, discussing the management’s decision...
Dear Fellow Shareholders, FPA New Income Fund (MUTF:FPNIX, the “Fund”) returned 0.21% in the second quarter of 2023 and 2.24% year-to- date through June...
Dear Shareholder Performance Overview The FPA Crescent Fund – Institutional Class (MUTF:FPCSX, “Fund” or “Crescent”) gained 6.29% in Q2 2023 and 16.13% in the...
In the dynamic world of pharmaceuticals, Merck & Co., Inc. (NYSE:MRK) has consistently emerged as a formidable player, showcasing resilience and innovation. While recent...
Introduction Regeneron Pharmaceuticals (NASDAQ:REGN) is a leading biotech firm that invents, develops, manufactures, and sells medicines for serious illnesses, including eye diseases, allergies, cancer,...